Clinical Trials Browser

INDUSTRY × Blood Specimen Collection × CNS × Clear all

NCT03860207 2023-09-13

Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers

Phase 1/2 Terminated

12 enrolled 15 charts

Neuroblastoma, Osteosarcoma

NCT01071837 2015-06-16

APG101 in Glioblastoma

Phase 2 Completed

Glioblastoma